A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignancies
Authors:
Open Access
- 23 June 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (27) , 23631-23646
Abstract
Tyrosine kinase inhibitors (TKI) have improved CML response rates, and some are effective against resistance-promoting point mutations in BCR-ABL1. However, in the absence of point mutations, resistance still occurs. Here, we identify a novel pathway mediating resistance which connects p47phox, the organizer subunit of NADPH oxidase-2 (NOX2), with early growth response-1 (Egr-1) and the Src family kinase Fyn. We found up-regulation of p47phox, Egr-1, and Fyn mRNA and protein using paired isogenic CML cell lines and mined data. Isolation of CD34+ cells and tissue microarray staining from blast crisis CML patients confirmed in vivo over-expression of components of this pathway. Knockdown studies revealed that p47phox modulated reactive oxygen species and Egr-1 expression, which, in turn, controlled Fyn expression. Interestingly, Fyn knockdown sensitized TKI-resistant cells to dasatinib, a dual BCR-ABL1/Src inhibitor. Egr-1 knockdown had similar effects, indicating the utility of targeting Fyn expression over activation. Pointedly, p47phox knockdown also restored TKI-sensitivity, indicating that targeting the NOX2 complex can overcome resistance. The NOX2/Egr-1/Fyn pathway was also conserved within TKI-resistant EGFRΔIII-expressing glioblastoma and patient-derived glioblastoma stem cells. Thus, our findings suggest that targeting the NOX2/Egr-1/Fyn pathway may have clinical implications within multiple cancer types; particularly where efficacy of TKI is compromised.Keywords
This publication has 79 references indexed in Scilit:
- The EGFR family members sustain the neoplastic phenotype of ALK+ lung adenocarcinoma via EGR1Oncogenesis, 2013
- Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapyCancer, 2012
- Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2Free Radical Biology and Medicine, 2011
- Gene expression signatures associated with the in vitro resistance to two tyrosine kinase inhibitors, nilotinib and imatinibBlood Cancer Journal, 2011
- Inhibition of IGF‐IR tyrosine kinase induces apoptosis and cell cycle arrest in imatinib‐resistant chronic myeloid leukaemia cellsJournal of Cellular and Molecular Medicine, 2010
- Targeted Knockdown of EGR-1 Inhibits IL-8 Production and IL-8-mediated Invasion of Prostate Cancer Cells through Suppressing EGR-1/NF-κB SynergyJournal of Biological Chemistry, 2009
- Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing CellsJournal of Biological Chemistry, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemiaBlood, 2008
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006